Fundz

HMNC closes $50 million Series B round led by MEDICE. The funding will accelerate the late-stage development of therapies for depression.

PRIVATEJun 15, 2026

Amount Raised

$50 Million

Round Type

Series B

BiotechnologyHealth CareTherapeutics

Investors

Medice

Description

Clinical-stage neuroscience company HMNC has closed the first $50 million tranche of its Series B financing. The capital will be used to accelerate late-stage development of two depression therapies. MEDICE has secured exclusive European commercialization rights for KET01 alongside the investment.

Quick answer

HMNC raised $50 Million in a Series B round, dated June 15, 2026. Investors: Medice.

How much did HMNC raise?
HMNC raised $50 Million in a Series B round on June 15, 2026.
Who invested in HMNC?
Medice is named as investors in this round.
What does HMNC do?
HMNC is a clinical-stage neuroscience company focused on developing innovative therapies for mental health disorders, particularly depression.
Who are the decision-makers at HMNC?
Fundz holds 2 contacts at HMNC, including the Vice President Clinical Development. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as HMNC that raised within 45 days of this round, from Fundz verified event records.

  • Hyku Biosciences raised $8.6M on July 30, 2026.
  • HCW Biologics raised $1.5M (Post-IPO Equity) on July 29, 2026.
  • Adjuvia Therapeutics raised $8M (Seed) on July 29, 2026.
  • CORE Biomedicine raised $21M (Series A) on July 28, 2026.
  • Torrey Pines Medicine raised an undisclosed amount (Angel) on July 28, 2026.
  • Definium Therapeutics raised $805M (Post-IPO Equity) on July 24, 2026.

Who to call at HMNC, and when

A new round usually means HMNC is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day HMNC raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at HMNC, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at HMNC. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

HMNC

About

HMNC is a clinical-stage neuroscience company focused on developing innovative therapies for mental health disorders, particularly depression. They are advancing programs designed to offer precision psychiatry approaches, including treatments for treatment-resistant depression. Their lead therapy, KET01, is a unique oral ketamine formulation aimed at improving access to treatment options. The company is also developing BH-200, a targeted therapy for biologically defined depressive disorders.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment HMNC raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsEvangelos, Vice President Clinical Development hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for HMNC's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

HMNC raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.